Start Scientific, Inc.
STSC · OTC
12/31/2018 | 12/31/2017 | 12/31/2016 | 12/31/2015 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -0.71 | 0.07 | 0.01 | 0.00 |
| FCF Yield | -10.49% | -4.67% | -56.48% | -134.27% |
| EV / EBITDA | -21.61 | -120.85 | -397.79 | -0.64 |
| Quality | ||||
| ROIC | 75.75% | 5.93% | 0.22% | 103.55% |
| Gross Margin | 0.00% | 0.00% | 0.00% | 0.00% |
| Cash Conversion Ratio | 3.40 | 2.75 | 0.63 | 0.09 |
| Growth | ||||
| Revenue 3-Year CAGR | – | – | – | – |
| Free Cash Flow Growth | -156.56% | 89.09% | -27.71% | -361.44% |
| Safety | ||||
| Net Debt / EBITDA | -13.45 | -72.98 | -263.26 | -0.54 |
| Interest Coverage | -0.80 | -0.13 | -0.02 | -2.92 |
| Efficiency | ||||
| Inventory Turnover | 0.00 | 0.00 | 0.00 | 0.00 |
| Cash Conversion Cycle | 0.00 | 0.00 | 0.00 | 0.00 |